Discover 1,846 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you're a healthy volunteer interested in paid studies or someone looking for trials focused on specific conditions, Tennessee offers a wide variety of clinical research options. Leading facilities in Nashville, Memphis, and Knoxville are currently seeking participants, providing opportunities for individuals to access innovative treatments and specialized healthcare.
Filter
1
Filter results
Results: 1,846
Active & Responsive
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
for
Smoking Cessation
Location: Brooklyn NY, Newport News VA, DeLand FL, Orlando FL,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07766655
Phase3, Recruiting
Active & Responsive
RA-PRO PRAGMATIC TRIAL
for
Rheumatoid Arthritis
Location: Boston MA, Worcester MA, New York NY, Exton PA,
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT04363684
Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
for
Irritable Bowel Syndrome
Location: Boston MA, Brooklyn NY, Laurel MD, Chevy Chase MD,
Sponsor: Dynogen Pharmaceuticals
Sex: Female
Age: 18 - 65
Code: NCT00547469
Phase2, Phase3, Recruiting
Active & ResponsiveNew
JUR-003 in Adult Patients With Metastatic Prostate Cancer
for
Metastatic Castration Resistant Prostate Cancer,
Location: Lake Success NY, Grand Rapids MI, Nashville TN
Sponsor: Juri Biosciences, Inc.
Sex: Male
Age: 18+
Code: NCT07824349
Phase1, Recruiting
Active & ResponsiveNew
Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC
for
Prostate Cancer, Castration-Resistant Prostate Cancer (CRPC),
Location: Nashville TN
Sponsor: Janux Therapeutics
Sex: Male
Age: 18+
Code: NCT07813637
Phase1, Recruiting
Active & ResponsiveNew
Beginning to Assess an Appropriate CONtrol for Oral Food Challenges in Alpha-Gal Syndrome (CoFAR-13) - BeACON4AG
for
Alpha-Gal Syndrome, Allergy
Location: Nashville TN
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 12 - 50
Code: NCT07611435
Phase2, Recruiting
Active & ResponsiveNew
Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE
for
Atherosclerotic Cardiovascular Disease
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 18+
Code: NCT07594392
Recruiting
Active & ResponsiveNew
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
for
Cutaneous Melanoma
Location: Patchogue NY, Stony Brook NY, Berlin Corners VT,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 70+
Code: NCT07068074
Phase3, Recruiting
Active & ResponsiveNew
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
for
Overweight , Obesity, Adults
Location: New York NY, Wilmington NC, Orlando FL, Nashville TN,
Sponsor: Alveus Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07837973
Phase2, Recruiting
Active & Responsive
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
for
Tachycardia, Ventricular
Location: Boston MA, Hartford CT, Philadelphia PA, Charleston SC,
Sponsor: Varian, a Siemens Healthineers Company
Sex: All
Age: 18+
Code: NCT05765175
Recruiting
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: Brewer ME, Augusta ME, Weymouth MA, Boston MA,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 60+
Code: NCT06377852
Phase3, Recruiting
Active & Responsive
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
for
Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma
Location: Fairfax VA, Huntersville NC, Nashville TN,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05431270
Phase1, Phase2, Recruiting
Active & Responsive
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
for
Generalized Myasthenia Gravis
Location: Farmington CT, Burlington VT, Washington D.C. DC,
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Sex: All
Age: 18+
Code: NCT06463587
Phase3, Recruiting
Active & Responsive
Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]
for
Lymphedema of the Head and Neck
Location: Philadelphia PA, Nashville TN
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT06125743
Recruiting
Active & Responsive
FOG-001 in Locally Advanced or Metastatic Solid Tumors
for
Cancer, Colorectal Cancer, Solid Tumor,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Parabilis Medicines, Inc.
Sex: All
Age: 18+
Code: NCT05919264
Phase1, Phase2, Recruiting
Active & Responsive
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor, Adult, ERBB2 Altered Breast Cancer,
Location: New Haven CT, Lake Success NY, New York NY, Fairfax VA,